This week’s OncoDaily GI curation spans some of the most exciting fronts in gastrointestinal oncology:
- A first-in-human Lynch syndrome vaccine trial, aiming to stop cancer before it starts.
- Liquid biopsy innovations for early pancreatic cancer detection.
- AI-driven pathology for predicting molecular profiles in HCC.
- New findings on microbiome-driven CRC and FGFR2-targeted BTC therapies.
- Plus: access strategies for cancer drugs, cutting-edge radiotherapy outcomes, and more.
Each post features insights from global leaders — from Francesc Balaguer to Catherine Alix-Panabières — offering a window into how prevention, precision medicine, and equity are reshaping GI cancer care.